• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec19
GT Biopharma Announces Shift Toward Precision Medicine in Oncology Industry
13:16
Dec11
GT Biopharma's 1st Phase Clinical Trial for Blood Cancers Shows Promising Results
15:19
Nov17
Jonathan Aschoff Maintains Buy Rating on GT Biopharma
17:02
Nov15
GT Biopharma released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -1.7053
04:00
GT Biopharma released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8267 (forecast USD -0.38)
04:00
Oct23
GT Biopharma completes first phase trial for cancer drug
15:27

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.258 M, EPS -0.8267

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.518 M, EPS -0.5476

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -776 K, EPS -0.3309

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More